Our Multi-Site Model

By combining our full suite of CRO support services and a network of strategic site partners globally, we manage complex multi-site studies in patients and healthy normal volunteers across a diverse range of therapeutic areas and trial designs.

Our team has significant experience managing external site activities, including site feasibility and management, for the seamless delivery of high-quality data to our sponsors. We maintain a network of strategic sites that have a diverse range of capabilities and patient populations to conduct multi-site clinical studies. Our comprehensive site feasibility and selection process ensures that the most capable sites participate in your study and align with our commitment to speed, customer service and delivering the cleanest data possible.

Our model prioritizes sites that align with these principles to help our sponsors reach their milestones faster.

R

Site ID and Selection

Quality over quantity is imperative for a successful model as we are not trying to be all things to everyone.

R

Prioritizing Site Payments

Sites need quicker payments to avoid study delays. This reinforces our collaborative, true partnership approach. 

R

Site Engagement

We are committed to being a true partner, providing sites with essential tools, support and prioritizing transparent communication and collaboration.

Central Laboratory Services

DVCR’s Central Laboratory streamlines multi-site trials through standardized processes, centralized testing and real-time data integration. We have customizable kits, next-day turnaround times and proactive shipment monitoring. With a single comprehensive Central Lab Manual and dedicated support teams, DVCR reduces site burden and quickly adapts to protocol changes – keeping your study on track from start to finish.

Florence Trial Operations Platform

Florence Trial Operations Platform accelerates our study startup and enables seamless document distribution, tracking and remote monitoring across investigator sites. It provides real-time visibility and quality control, eliminating the need for back-and-forth exchanges and integrates directly with Trial Master Files (TMFs) for efficient filing and document updates. Whether sites use a Florence account or paper ISF, this tool keeps DVCR connected and informed—especially during critical phases, such as startup and site activation.

CNS, Psychiatry & Neurology

Substance Use Disorders (SUD) & Addiction

Allergy & Immunology

Obesity

Pain

Respiratory

Dermatology

Infectious Diseases

CNS, Psychiatry & Neurology

Substance Use Disorders (SUD) & Addiction

Allergy & Immunology

Obesity

Pain

Respiratory

Dermatology

Infectious Diseases

CNS, Psychiatry & Neurology

Substance Use Disorders (SUD) & Addiction

Allergy & Immunology

Obesity

Pain

Respiratory

Dermatology

Infectious Diseases

Press Release

Dr. Vince Clinical Research Announces First Dosing in Atopic Dermatitis Patients with Enveda’s First-in-Class Investigational Drug ENV-294

Press Release

Dr. Vince Clinical Research Announces First Dosing in a Phase II Study in Patients with Depression

Press Release

Dr. Vince Clinical Research Announces First Dosing in Cingulate Therapeutics’ CTx-1301 Phase III Laboratory Classroom Study in ADHD Patients

Contact Us

Multi-Site Clinical Trial Inquiry

This field is for validation purposes and should be left unchanged.
Name(Required)